Form 4 for ALXO ALX ONCOLOGY HOLDINGS INC
Accepted 2022-08-09 00:00:00 ET · period of report 2022-08-05 · accession 0001209191-22-045067 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-08-09 | 2022-08-05 | ALXO | Randolph Sophia | Chief Medical Off, Dir | A - Grant | $0.00 | +37.0K | 225.4K | +20% | $0 |
| D | 2022-08-09 | 2022-08-05 | ALXO | Randolph Sophia | Chief Medical Off, Dir | A - Grant | $0.00 | +123.0K | 123.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-05 | A | A | 37,000 | $0.00 | 225,396 | D | — | — | (F1) The reported shares are represented by restricted stock units, or RSUs, which vest in eight equal semiannual installments beginning on December 28, 2022. |
| 2 | Derivative | Employee Stock Option (right to buy) | 2022-08-05 | A | A | 123,000 | $0.00 | 123,000 | D | $11.47 · — to 2032-08-04 | 123,000 Common Stock | (F2) Shares subject to the option vest in 48 equal monthly installments beginning on August 1, 2022. |